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Objectives: A systematic review of the literature and meta-analysis was 
conducted to assess the nature and quality of the evidence for the use of 
hearing instruments in adults with a unilateral severe to profound sen-
sorineural hearing loss.
Design: The PubMed, EMBASE, MEDLINE, Cochrane, CINAHL, and DARE 
databases were searched with no restrictions on language. The search 
included articles from the start of each database until February 11, 2015. 
Studies were included that (a) assessed the impact of any form of hear-
ing instrument, including devices that reroute signals between the ears 
or restore aspects of hearing to a deaf ear, in adults with a sensorineural 
severe to profound loss in one ear and normal or near-normal hearing in 
the other ear; (b) compared different devices or compared a device with 
placebo or the unaided condition; (c) measured outcomes in terms of 
speech perception, spatial listening, or quality of life; (d) were prospec-
tive controlled or observational studies. Studies that met prospectively 
defined criteria were subjected to random effects meta-analyses.
Results: Twenty-seven studies reported in 30 articles were included. The 
evidence was graded as low-to-moderate quality having been obtained 
primarily from observational before-after comparisons. The meta-analysis 
identified statistically significant benefits to speech perception in noise for 
devices that rerouted the speech signals of interest from the worse ear to 
the better ear using either air or bone conduction (mean benefit, 2.5 dB). 
However, these devices also degraded speech understanding significantly 
and to a similar extent (mean deficit, 3.1 dB) when noise was rerouted 
to the better ear. Data on the effects of cochlear implantation on speech 
perception could not be pooled as the prospectively defined criteria for 
meta-analysis were not met. Inconsistency in the assessment of outcomes 
relating to sound localization also precluded the synthesis of evidence 
across studies. Evidence for the relative efficacy of different devices was 
sparse but a statistically significant advantage was observed for rerouting 
speech signals using abutment-mounted bone conduction devices when 
compared with outcomes after preoperative trials of air conduction devices 
when speech and noise were colocated (mean benefit, 1.5 dB). Patients 
reported significant improvements in hearing-related quality of life with 
both rerouting devices and following cochlear implantation. Only two stud-
ies measured health-related quality of life and findings were inconclusive.
Conclusions: Devices that reroute sounds from an ear with a severe to pro-
found hearing loss to an ear with minimal hearing loss may improve speech 
perception in noise when signals of interest are located toward the impaired 
ear. However, the same device may also degrade speech perception as all 
signals are rerouted indiscriminately, including noise. Although the restora-
tion of functional hearing in both ears through cochlear implantation could 
be expected to provide benefits to speech perception, the inability to syn-
thesize evidence across existing studies means that such a conclusion can-
not yet be made. For the same reason, it remains unclear whether cochlear 
implantation can improve the ability to localize sounds despite restoring 
bilateral input. Prospective controlled studies that measure outcomes con-
sistently and control for selection and observation biases are required to 
improve the quality of the evidence for the provision of hearing instruments 
to patients with unilateral deafness and to support any future recommenda-
tions for the clinical management of these patients.
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Contralateral routing of signals, Localization, Meta-analysis, Quality of life, 
Re-routing devices, Restorative devices, Single-sided deafness, Speech 
perception, Systematic review, Unilateral deafness, Unilateral hearing loss.
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INTRODUCTION
The onset of unilateral deafness in adulthood is often sudden 
and idiopathic (Baguley et al. 2006). Even a small asymmetry 
between the ears has the potential to impose an audiological 
handicap, particularly in situations with multiple people speak-
ing at the same time (Noble & Gatehouse 2004). Consequently, 
the near or total loss of hearing in one ear gives rise to substan-
tial difficulties with listening in most everyday situations (Dwyer 
et al. 2014). Unilateral deafness impairs the ability to understand 
speech in noise and to localize sounds and also limits awareness 
of sounds that are located on the side of the impaired ear (IE; 
McLeod et al. 2008). These difficulties and their consequences 
for social and vocational activities can lead to feelings of annoy-
ance, embarrassment, and helplessness (Giolas & Wark 1967).
One approach to improve the awareness of sounds on the side 
of the IE is to reroute signals to the contralateral, nonimpaired 
ear. This contralateral routing of signals was first achieved by 
connecting a hearing aid microphone on the side of the IE to a 
hearing aid on the non-IE (Harford & Barry 1965; Harford & 
Dodds 1966). A similar result is now achieved via wireless com-
munication between two behind-the-ear devices (Valente 1995). 
Due to limitations in the frequency response of early rerout-
ing devices, an alternative approach was to fit a high-powered 
in-the-ear-canal hearing aid in the IE to stimulate the nonim-
paired cochlea via conduction through the cranial bones (Valente 
et al. 1995). Candidacy for bone-anchored hearing devices that 
were originally developed for conductive or mixed losses has 
also been extended to include unilateral sensorineural deafness 
(Niparko et al. 2003). Recently, cochlear implantation (CI) has 
been considered for unilateral deafness, initially for suppress-
ing tinnitus (Van de Heyning et al. 2008) but subsequently for 
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the restoration of binaural hearing (Vermeire & Van de Heyning 
2009).
Related Systematic Reviews
Baguley et al. (2006) compared outcomes with bone- and air 
conduction rerouting devices (BCD and ACD, respectively) in 
adults with a unilateral sensorineural deafness. A meta-analysis 
of four studies suggested that BCD may provide additional ben-
efits over ACD by improving speech perception in noise and 
reducing self-reported listening difficulties. Neither device 
improved the ability to localize sounds. Peters et al. (2015) 
also compared the evidence for ACD and BCD. Six studies 
provided evidence for a reduction in self-reported difficulties 
from the use of rerouting devices. A clear advantage for either 
conduction modality was not observed. Neither review included 
studies evaluating the effectiveness of devices in one conduc-
tion modality only compared with the unaided condition. No 
systematic review was identified whose stated purpose was to 
review the evidence for rerouting devices compared with the 
unaided condition. Both van Zon et al. (2015) and Blasco and 
Redleaf (2014) reviewed the evidence for CI in adults with uni-
lateral deafness. Both reviews identified some benefits to sound 
localization, listening difficulties, and quality of life after CI.
Comparing the evidence for the different interventions 
(ACD, BCD, and CI) across these reviews is restricted by dif-
ferences in their inclusion criteria, limitations on the language 
of included articles, quality assessment procedures, and meth-
odologies for synthesizing evidence. No previous review has 
permitted the inclusion of studies that assessed any forms of 
hearing instruments other than ACD, BCD, and CI.
Purpose
A systematic review of the literature was conducted to assess 
the evidence for whether hearing instruments, including but not 
limited to rerouting devices and any device that restores input 
to the IE (“restorative devices”), are effective in improving lis-
tening skills impaired in unilateral deafness (speech perception 
and sound localization), reducing associated listening difficulty 
(hearing-related quality of life), and improving overall health 
and well-being (health-related quality of life). The review 
also sought to compare restorative and rerouting devices, and 
to compare air- and bone conduction rerouting devices to the 
unaided condition. All previous reviews have noted a lack of 
randomized controlled trials and therefore the review included 
both prospective controlled and observational studies.
The difficulties with understanding speech reported by uni-
laterally deaf adults result in part from the attenuating effect of 
the head’s acoustic shadow on talkers located toward the IE (Har-
ford et al. 1966). It was, therefore, anticipated that rerouting and 
restorative devices would improve speech perception in noise 
when speech signals were presented toward the IE, as both over-
come the head shadow effect. As a result of these effects, both 
categories of device were also expected to lead to reductions in 
at least some forms of difficulty with listening in everyday situ-
ations. Difficulties with the spatial aspects of hearing reported 
by these individuals result from impaired access to the binau-
ral cues of interaural level and time (Noble & Gatehouse 2004). 
It was, therefore, hypothesized that restorative devices would 
improve the ability to localize sounds by restoring functional 
hearing in both ears, an ability that would not be restored by 
rerouting devices as they do not provide input bilaterally.
MATERIALS AND METHODS
A systematic review of the literature was carried out in 
accordance with recommendations for undertaking (Centre 
for Reviews and Dissemination 2009; Higgins & Green 2009) 
and reporting (Stroup et al. 2000; Moher et al. 2009) reviews 
of healthcare interventions. Before commencing the review, an 
unpublished internal protocol was developed that specified the 
search strategy, selection criteria, data extraction procedures, 
method of quality assessment, and terms under which study 
data would be pooled for meta-analysis.
Search Strategy
A literature search was conducted by the investigators of the 
following electronic databases: MEDLINE, EMBASE, PubMed, 
CINAHL, DARE, and the Cochrane Databases. The MEDLINE 
and EMBASE databases were searched using the OvidSP soft-
ware (Ovid Technologies Ltd.). Other databases were searched 
using their public-facing websites. The search was conducted 
with no restrictions on language from 1946 or the start date of 
the database, whichever was earlier. The search results were last 
updated on February 11, 2015 (see Table, Supplemental Digital 
Content 1 (http://links.lww.com/EANDH/A264), which lists a 
representative example of the search strategy adapted for the 
MEDLINE and EMBASE databases).
Selection Criteria
The criteria for inclusion in the review were defined in 
terms of participants, intervention(s), comparators, out-
comes, and study designs (PICOS) as follows: (P) adults 
with a pure-tone average audiometric threshold ≤30 dB HL 
in one ear (averaged across 0.5, 1, 2, and 4 kHz) and >70 dB 
HL in the other ear. The description of the poorer ear should 
indicate that the loss was sensorineural in origin or that the 
sensorineural component was severe to profound. Where the 
description does not rule out well-preserved cochlear func-
tion and bone conduction thresholds are reported, the air 
bone gap should be ≤10 dB from 1 to 4 kHz; (I) any hear-
ing instrument; (C) hearing instruments and placebo devices, 
no intervention; (O) speech perception in quiet and in noise, 
sound localization, hearing- and health-related quality of life, 
complications and adverse events; (S) controlled trials and 
prospective observational studies. Studies that included other 
populations had to report data from the eligible population 
separately. The minimum duration of follow-up was 1 week 
for rerouting devices and 3 months for restorative devices 
to ensure there was sufficient time for acclimatization. All 
studies were reviewed independently by PTK and SNS. Ini-
tial screening was conducted based on titles and abstracts. 
Full text articles were retrieved for screening where any 
uncertainty existed about a study’s eligibility. Authors were 
contacted if other methods of obtaining study information 
were unsuccessful. Foreign language articles were translated. 
Disagreements between reviewers were resolved by consen-
sus. Reference lists of articles that met the inclusion criteria 
were also searched for potentially eligible articles. Published 
abstracts, articles published in nonpeer reviewed publications 
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(“gray literature”), and unpublished studies were not included 
in this review.
Data Extraction
Information was extracted from each study under the follow-
ing headings: number of patients, type of intervention device, 
type of comparator device, control group, outcomes, duration of 
follow-up, and level of evidence. Levels of evidence were deter-
mined based on study design and other quality factors (Centre 
for Evidence-Based Medicine 2009). The form used for data 
extraction was piloted on a small number of studies before use. 
Data extraction was performed independently by SNS and LL. 
Where data were extracted from the text of articles, disagree-
ments were resolved by a third author (PTK). Disagreements 
about numerical data extracted from figures were resolved by 
averaging.
Quality Assessment
A quality assessment was conducted based on selected 
factors that may increase the risk of bias (Downs & Black 
1998). The quality factors were randomized allocation, blind-
ing, ethical approval, statement of eligibility criteria, power 
calculation, appropriate control group, confounds identified 
and controlled for, missing data accounted for, and funding 
source(s) declared. Quality assessments were conducted at 
the study level and were performed independently by SNS and 
LL with disagreements resolved by consensus. The results of 
the quality assessment were used to assess the risk that the 
observed results may have been biased due to the manner in 
which the study was conducted.
Meta-Analysis and Data Synthesis
The quality assessment was not used to select studies for 
meta-analysis due to the lack of a validated set of quality cri-
teria upon which to base selection (Jüni et al. 1999). Instead, 
data were pooled and subjected to meta-analysis if a standard-
ized self-report instrument or assessment methodology was 
used and there was no substantial difference in design between 
the studies that were pooled into a single meta-analysis. Where 
these criteria were met, data were subjected to a random effects 
meta-analysis with a restricted maximum-likelihood estima-
tor using the “metafor” package for the R statistical software 
(Viechtbauer 2010). The use of a random effects approach to 
the meta-analysis was based on an assumption that effect sizes 
would vary across studies not only due to the fact that they used 
different samples of participants (as assumed in a fixed effect 
approach) but also due to differences in the way the studies were 
conducted (Borenstein et al. 2010).
Effect sizes were calculated as standardized mean dif-
ferences (SMDs) in which the mean difference between 
treatments was divided by the pooled standard deviation 
(between group) or by the SD of the differences (within 
group). Heterogeneity was described by expressing the total 
heterogeneity as a percentage of the total variability (I2) and 
its significance was tested using a χ2 test. This approach to 
quantifying heterogeneity provides an intuitive value from 
0 to 100% where a higher value indicates greater inconsis-
tency in effect sizes across studies. I2 values less than 40% 
and for which the associated χ2 test was also nonsignificant 
(p > 0.10) were considered as indicative of low heterogene-
ity (Higgins & Green 2009). Publication bias was assessed 
using the trim and fill method (Duval & Tweedie 2000). An 
estimate of the number of missing studies was derived using 
the R0 estimator to test the null hypothesis that the number of 
missing studies was zero (Duval 2005). If the null hypothesis 
was rejected, the sensitivity of the results to publication bias 
was assessed by calculating an adjusted summary estimate. 
The direction and statistical significance of the observed 
effects in each study were also tabulated.
RESULTS
A total of 778 articles were identified and subjected to a 
three-stage screening process (Fig. 1). The full texts of 298 
articles that passed the initial title and abstract screen were 
retrieved without requiring contact with authors. A total of 
249 articles were judged to not have met the inclusion criteria 
and were excluded (see Table, Supplemental Digital Content 
2 (http://links.lww.com/EANDH/A265), which provides addi-
tional details about the reasons for exclusions after full-text 
review). Of the remaining 49 articles that did meet the criteria, 
19 were excluded either because the duration of follow-up was 
insufficient or outcomes for the eligible population were not 
reported separately (Table 1). Therefore, 30 articles reporting 
27 separate studies were included in the review (Table 2).
Fig. 1. Flow chart of the process for selecting studies for inclusion in the 
review.
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The studies evaluated hearing instruments that fell into the 
broad categories of rerouting devices and restorative devices. The 
rerouting devices included those based on ACD and BCD. The 
restorative devices were limited to CIs. No other form of hearing 
instrument was identified in the screening process. The compara-
tors for both categories of device included the unaided condition 
and other rerouting devices. All studies that assessed ACDs com-
pared them with BCDs, with two studies randomizing the order of 
the interventions (Hol et al. 2010b; Arndt et al. 2011a, b) and four 
studies evaluating ACD use before BCD use (Bosman et al. 2003; 
Niparko et al. 2003; Wazen et al. 2003; Lin et al. 2006). Bone con-
duction rerouting devices included those mounted on a head-band, 
on a surgically inserted abutment, on an oral prosthesis, and those 
inserted into the ear canal. As there were no a priori expectations 
about differences between these varying approaches to bone con-
duction, all BCD devices were grouped together for all analyses.
The majority of studies were before-after comparisons 
in which patients acted as their own control. Three studies 
included matched control groups that did not receive a hear-
ing instrument, two of which were case–control designs (Gluth 
et al. 2010; House et al. 2010) and one was a cohort study 
(Punte et al. 2013). The minimum duration of follow-up var-
ied considerably and was dependent on the type of intervention. 
All studies assessing outcomes after CI followed patients for at 
least 6 months, whereas follow-up periods were far shorter for 
studies of rerouting devices, with one study following patients 
for only 18 days (Desmet et al. 2012). This variation reflects the 
fact that rerouting devices present additional information to an 
already-functioning ear, whereas CIs require a longer period of 
adjustment to the novel form of stimulation in the deaf ear.
The studies were judged to be of low-to-moderate quality. None 
reported conducting a power calculation. Seven studies (26%) 
included a control group but four of those used nonmatched con-
trols (individuals with normal hearing or conductive hearing losses). 
None reported identifying or controlling for confounding factors. 
Four studies (15%) randomized the order of interventions but did 
not provide any information about randomization methodology or 
concealment according to best-practice guidelines for the reporting 
of randomized controlled trials (Schulz et al. 2010). None of these 
four studies reported outcomes based on participants’ initial alloca-
tion and used randomization to control for order effects when pro-
viding multiple interventions to the same participants rather than 
to control for biases. Missing data were controlled for in only two 
studies (7%) and by excluding participants with incomplete data, 
an approach that can introduce bias if those who failed to return for 
follow-up appointments did so because of lack of benefit (Nüesch 
et al. 2009). Ten studies (37%) did not state clear eligibility criteria, 
18 studies (67%) did not declare funding sources, and 11 studies 
(41%) did not state whether ethical approval had been obtained.
Due to heterogeneity in the design and outcomes of those studies 
that included control groups, summary effect sizes based on a ran-
dom effects meta-analysis were computed for within-group effects 
only. No evidence of publication bias was found using the trim and 
fill method and therefore adjusted summary effect sizes were not 
calculated. Effect sizes were categorized as small, medium, or large 
if their value exceeded 0.3, 0.7, or 1.2 based on an average pre-post 
correlation of 0.53 (Barcikowski & Robey 1985). The statistical 
significance and direction of effects within studies (Tables 3 and 
4; see Tables, Supplemental Digital Contents 3 and 4, for anno-
tated version of these tables) and the results of the meta-analysis of 
effects across studies (Figs. 2 and 3, Table 5) are discussed for each 
outcome measure separately in the following sections.
Speech Perception in Quiet
Rerouting Versus Unaided • Five studies examined the 
effect of using a rerouting device on speech perception in quiet 
(Tables 3 and 4, “SIQ”). Speech perception was evaluated using 
either the HINT sentence test (Nilsson et al. 1994) or the Leuven 
Intelligibility Sentence test (Van Wieringen & Wouters 2008). 
TABLE 1. Articles that met the inclusion criteria but were excluded from the review with justification (see Table, Supplemental Digital 
Content 2 (http://links.lww.com/EANDH/A265), for further information on the reasons for excluding articles that did not meet the 
inclusion criteria)
Study Reason for Exclusion Justification
Andersen et al. (2006) Insufficient follow-up Patients were assessed only 1 hr after device fitting
Blackmore et al. (2007) Data reporting Included patients with mixed hearing loss in impaired ear
Desmet et al. (2014) Data reporting Some patients had hearing outside of inclusion criteria in nonimpaired ear
Harford and Dodds (1966) Insufficient follow-up Patients were assessed acutely at time of fitting
Hol et al. (2005) Data reporting Some patients had hearing outside of inclusion criteria in nonimpaired ear
Hol et al. (2010a) Data reporting Some patients had hearing outside of inclusion criteria in nonimpaired ear
José et al. (2011) Data reporting Some patients had hearing outside of inclusion criteria in nonimpaired ear
Kim et al. (2014) Data reporting Included patients with moderate hearing loss in impaired ear
Kompis et al. (2011) Data reporting Included patients with hearing loss outside of inclusion criteria in one or both ears
Linstrom et al. (2009) Data reporting Included patients with moderate and mixed hearing losses in impaired ear
Martin et al. (2010) Data reporting Some patients had hearing outside of inclusion criteria in nonimpaired ear
Pfiffner et al. (2011) Data reporting Included patients with mixed hearing loss in impaired ear
Popelka (2010) Data reporting Included patients with hearing loss outside of inclusion criteria in impaired ear
Popelka et al. (2010) Data reporting Included patients with hearing loss outside of inclusion criteria in one or both ears
Saroul et al. (2013) Data reporting Included children
Snapp et al. (2012) Data reporting Included patients with moderate hearing loss in impaired ear
Snapp et al. (2010) Data reporting Included patients with hearing loss outside of inclusion criteria in one or both ears
Upfold (1980) Insufficient follow-up Patients were assessed acutely at time of fitting
van Wieringen et al. (2011) Data reporting Included patients with an air bone gap >10 dB in one or both ears
Insufficient follow-up: follow-up period was less than the minimum required (1 week for rerouting devices, 3 months for restorative devices). Data reporting: did not report data from eligible 
patient population separately from other noneligible population(s).
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In all five studies, speech was presented directly in front of the 
patient. The only statistically significant effect in any individual 
study was a decrease in speech perception accuracy when par-
ticipants used an ACD (Lin et al. 2006). Meta-analyses of two 
studies evaluating ACD effects (Niparko et al. 2003; Wazen et 
al. 2003) and three studies evaluating BCD effects (Niparko et 
al. 2003; Wazen et al. 2003; Dumper et al. 2009) identified no 
significant change in speech-reception thresholds (SRT) follow-
ing use of either type of device (see Figure, Supplemental Digital 
Content 5 and 6 (http://links.lww.com/EANDH/A268 and http://
links.lww.com/EANDH/A269), which list the individual study 
estimates for ACD and BCD, respectively). No significant hetero-
geneity across the studies was observed (Table 5, “HINT-SIQ”).
BCD Versus ACD • Of those studies that compared ACD and 
BCD effects on speech perception in quiet, only one study found 
significantly greater benefits from bone conduction (Table 4). 
However, no statistically significant effect was observed when 
data were pooled across the two studies that reported SRTs 
in quiet (Niparko et al. 2003; Wazen et al. 2003). Significant 
heterogeneity in their effect sizes was also observed (Table 5, 
“HINT-SIQ”; see Figure, Supplemental Digital Content 7 
(http://links.lww.com/EANDH/A270), which lists the individ-
ual study estimates for the difference between BCD and ACD).
CI Versus Unaided • Two studies reported a statistically sig-
nificant improvement in speech perception in quiet after CI 
(Table 4, “SIQ”). However, in both cases, speech perception was 
TABLE 2. Characteristics of studies included in the review
Study N (SSD) Intervention(s) Outcomes Controls
Maximum Duration 
of Follow-Up
Level of  
Evidence
Arndt et al. (2011a, 
2011b)
11 CI, BCD, ACD Localization, HSM, OLSA, SSQ, 
HUI3, IOI-HA, HHIE, tinnitus VAS
Own 3 wks (BCD,ACD)
12 mos (CI)
4*
Battista et al. (2013) 20 BCD Localization NH Acute 4
Bosman et al. (2003) 9 BCD, ACD Localization, APHAB Own 4 wks 4
Desmet et al. (2012) 10 BCD APHAB, SSDQ, SHQ, LIST, diary Own 18 days 4
Dumper et al. (2009) 15 BCD HINT, APHAB, SSQ Own Unknown 4
Gluth et al. (2010) 56 BCD APHAB, GHABP, SSDQ Matched 36 mos 3b
Grantham et al. (2012) 7 BCD Localization CHL, NH 12 mos 4
Hansen et al. (2013) 25 CI CNC, AzBio, localization Own 24 mos 4
Hol et al. (2010b) 10 BCD, ACD Speech in noise, localization, 
APHAB, SSQ, SSDQ, 
lateralization
Own 8 wks 4*
House et al. (2010) 129 BCD BAHA questionnaire, SSQ, APHAB Matched Unknown 3b
Jacob et al. (2011) 13 CI FBE, HSM, OLSA, localization Own 48 mos 4
Lin et al. (2006) 23 BCD, ACD APHAB, HINT, SAINT Own 1 mos 4
Moore and Popelka (2013) 9 BCD Localization, QuickSIN, APHAB NH 60 days 4†
Murray et al. (2011) 22 BCD APHAB, dental measures Own 6 mos 4
Newman et al. (2008, 
2010)
10 BCD SPIN-R, HINT, localization, 
APHAB, HHIA, SSDQ, SF-36, 
ECHO, SADL
Own 18 mos 4
Niparko et al. (2003) 10 BCD, ACD APHAB, GHABP, SAINT, HINT Own 1 mo (ACD)
4 mos (BCD)
4
Pai et al. (2012) 25 BCD SSQ Own 6 mos + 4
Punte et al. (2013) 14 CI Tinnitus VAS, TA, TQ Matched 6 mos 2b
Saliba et al. (2011) 21 BCD HINT, localization, APHAB Own 6 mos 4
Távora-Vieira et al. 
(2013)
5 CI BKB-SIN, SSQ, CUNY Own 12 mos 4
Punte et al. (2011),  
Van de Heyning et al. 
(2008)
26 CI Tinnitus VAS, TQ Own 24 mos 4
Vermeire and Van de 
Heyning (2009)
20 CI LIST, SSQ Own 12 mos 4
Wazen et al. (2005) 8 BCD Localization NH Unknown 4
Wazen et al. (2003) 18 BCD, ACD HINT, APHAB, SSDQ Own 4 mos 4
Weber et al. (1992) 8 BCD SPIN, localization Own Unknown 4
Wesarg et al. (2013) 11 BCD HSM, OLSA, localization Own 12 mos (1st 
processor)
6 wks (2nd 
processor)
4†
Yuen et al. (2009) 21 BCD HINT, APHAB, GHABP Own 3 mos 4
*Randomized the order of ACD and BCD but did not report data based on initial allocation.
†Randomized order of two BCD models but did not report data based on initial allocation.
ACD, air conduction rerouting device; APHAB, abbreviated profile of hearing aid benefit; BCD, bone conduction rerouting device; CI, cochlear implant, CHL, conductive hearing loss; ECHO, 
expected consequences of hearing aid ownership; FBE, Freiburg Monosyllabic test; GHABP, Glasgow hearing aid benefit profile; HHIE, hearing handicap inventory for the elderly; HSM, 
Hochmair-Schulz-Moser sentence test; HUI3, health utilities index mark 3; IOI-HA, international outcomes inventory for hearing aids; NH, normal hearing; OLSA, Oldenburg Sentence test; 
SADL, satisfaction with amplification in daily life; SAINT, Source Azimuth Identification in Noise test; SSDQ, single-sided deafness questionnaire; SSQ, speech, spatial, and qualities of hearing; 
VAS, visual analogue scale.
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assessed when participants listened using only their implanted 
ear. Neither study reported equivalent outcomes when partici-
pants also had the use of their nonimplanted ear.
CI Versus Rerouting • No study compared speech perception 
in quiet with a CI and with any form of rerouting device.
Interim Summary • There is a lack of evidence to suggest that 
rerouting devices or CI can provide benefits to speech perception 
in quiet compared with the unaided condition, or that one cate-
gory of hearing instrument may be more beneficial than another.
Speech Perception in Noise
Studies varied the spatial location of the speech and noise stim-
uli relative to the IE or non-IE (NE). Spatial configurations were 
classified as either creating a similar signal to noise ratio (SNR) at 
the two ears (IE = NE), a more favorable SNR at the IE (IE > NE), 
or a less favorable SNR at the IE (IE < NE). Consistent assessment 
methodologies were only observed among studies that used the 
HINT sentence test and meta-analyses were conducted only where 
identical speech and noise locations were used across studies.
Rerouting Versus Unaided • Thirteen studies reported changes 
in speech perception in noise after use of a rerouting device 
(Tables 3 and 4, “SIN”). Individual studies found significant 
benefits for both ACD and BCD when the IE had a more favor-
able SNR than the NE (IE > NE). Conversely, statistically sig-
nificant deficits were found for both rerouting modalities when 
the IE had a less favorable SNR (IE < NE). When both ears had a 
similar SNR (IE = NE), significant benefits were only found for 
bone conduction. The number of studies reporting nonsignificant 
effects for all configurations of speech and noise was similar to or 
greater than the number reporting significant effects.
Meta-analyses of data from the HINT sentence test identified 
significant benefits from both BCD and ACD when speech was 
presented from in front and noise was presented toward the NE 
(Fig. 2; Table 5, “HINT-S0Nne”). SRTs were also impaired signifi-
cantly by both device types when noise was presented toward the IE 
(“HINT-S0Nie”). No significant effect of rerouting was identified 
when speech and noise were colocated (“HINT-S0N0”; see Fig-
ure, Supplemental Digital Content 5 and 6 (http://links.lww.com/
EANDH/A268 and http://links.lww.com/EANDH/A269), which 
list the individual study estimates for ACD and BCD, respectively).
BCD Versus ACD • Only one study reported significantly 
better speech perception in noise with BCD compared to ACD 
(Niparko et al. 2003). A meta-analysis of HINT data from two 
studies (Niparko et al. 2003; Wazen et al. 2003) found that out-
comes were more favorable with BCD but only when both ears 
had a similar SNR (Fig. 3; Table 5, “HINT-S0N0”; see Figure, 
Supplemental Digital Content 7 (http://links.lww.com/EANDH/
A270), which lists the individual study estimates for the differ-
ence between BCD and ACD).
CI Versus Unaided • Three of the four studies reporting 
speech perception in noise outcomes before and after CI found 
TABLE 3. Statistical significance and direction of effects for each category of outcome measure from studies that compared BCDs to the 
unaided condition (see Table, Supplemental Digital Content 3 (http://links.lww.com/EANDH/A266), for an annotated version of this table)
Study SIQ
SIN
Sound 
Localization
Hearing 
RQOL
Health 
RQOLIE > NE IE < NE IE = NE
BCD vs. unaided
  Arndt et al. (2011a, 2011b) − − = + +, − +
  Battista et al. (2013) +, −
  Bosman et al. (2003) + + = +
  Desmet et al. (2012) = ++, + =, − + ++, + , −
  Dumper et al. (2009) + +, − − − +, −
  Gluth et al. (2010) ++, +
  Grantham et al. (2012) −−
  Hol et al. (2010b) − +, − = +, −
  House et al. (2010) +, −
  Lin et al. (2006) = ++ −− = = =
  Moore and Popelka (2013) + = = + ++
  Murray et al. (2011) ++
  Newman et al. (2008, 2010) +, − = +, = =
  Niparko et al. (2003) + ++ −− ++ = +
  Pai et al. (2012) ++
  Saliba et al. (2011) ++, + −−, − − ++ ++, +, −
  Wazen et al. (2005) =
  Wazen et al. (2003) + + − + +
  Weber et al. (1992) = = =, +
  Wesarg et al. (2013) ++ −− ++ +
  Yuen et al. (2009) ++ − ++
Study totals
++ 0 6 0 2 1 7 0
Only +, =, or − 5 7 8 9 11 9 2
−− 0 0 4 0 1 0 0
BCD, bone conduction rerouting devices; Hearing/health RQOL, hearing/health-related quality of life; IE, impaired ear; IE < NE, less favorable SNR at the IE; IE > NE, more favorable SNR at 
the IE; IE = NE, similar SNRs at both ears; NE, nonimpaired ear; SIN, speech in noise; SIQ, speech in quiet; SNR, signal to noise ratio; ++, favors intervention statistically significant; +, favors 
intervention numerically; −−, favors comparator statistically significant; −, favors comparator numerically; =, no difference reported.
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significant benefits when the implanted ear had a more favor-
able SNR (IE > NE; Table 4, “SIN”). Only one study found 
significant benefits when both ears had a similar SNR (IE = 
NE; Távora-Vieira et al. 2013). Results for the spatial configu-
ration that created a more favorable SNR at the NE were incon-
clusive with no study reporting a significant benefit or deficit 
after implantation. Heterogeneity in the assessment method-
ologies meant that data could not be pooled across studies for 
meta-analysis.
CI Versus Rerouting • One study compared outcomes after 
CI with outcomes after the use of either ACD or BCD devices 
(Arndt et al. 2011a, 2011b). Speech perception was reported to be 
significantly better after CI compared with the preoperative use of 
both an ACD and BCD when either ear had a more favorable SNR.
Interim Summary • The available evidence suggests that 
rerouting devices provide benefits to speech perception in noise 
when the SNR is more favorable at the IE but degrade speech 
perception when the SNR is less favorable at the IE. There is 
an absence of evidence for any effect of rerouting signals on 
speech perception when the SNR is similar at both ears. There 
is also a lack of evidence for the effects of cochlear implant use 
on speech perception in noise due to variations in testing meth-
odologies across studies. The evidence for additional benefits 
from one device type over another is limited and inconclusive.
TABLE 4. Statistical significance and direction of effects for each category of outcome measure in studies that compared ACDs and 
CI with BCDs and to the unaided condition (see Table, Supplemental Digital Content 4, for an annotated version of this table)
Study SIQ
SIN
Sound 
Localization
Hearing 
RQOL
Health 
RQOLIE > NE IE < NE IE = NE
ACD vs. unaided
  Arndt et al. (2011a, 2011b) + − + − +, − +
  Bosman et al. (2003) + − = +, −
  Hol et al. (2010b) + − =3 +, −
  Lin et al. (2006) −− ++ −− = −− −−
  Niparko et al. (2003) − ++ −− − = +
  Wazen et al. (2003) + + − + +, −
Study totals
++ 0 2 0 0 0 0 0
Only +, =, or − 2 4 4 4 4 5 1
−− 1 0 2 0 1 1 0
CI vs. unaided
  Arndt et al. (2011a, 2011b) ++ = = ++ ++ +
  Hansen et al. (2013) ++* 4 +
  Jacob et al. (2011) = + 4 + +
  Punte et al. (2013) ++
  Távora-Vieira et al. (2013) ++* ++ ++ ++
  Punte et al. (2011), Van de 
Heyning et al. (2008)
++
  Vermeire and Van de Heyning 
(2009)
++ − + ++, +
Study totals
++ 2 3 0 1 1 5 0
Only +, =, or − 1 1 3 3 2 0 1
−− 0 0 0 0 0 0 0
BCD vs. ACD
  Arndt et al. (2011a, 2011b) − = − +
  Bosman et al. (2003) + = +
  Hol et al. (2010b) − +, − = +, −
  Lin et al. (2006) + − + + + +
  Niparko et al. (2003) ++ + + ++ = +
  Wazen et al. (2003) = + + + +
Study totals
++ 1 0 0 1 0 0 0
Only +, =, or − 2 6 5 3 5 5 0
−− 0 0 0 0 0 0 0
CI vs. BCD
  Arndt et al. (2011a, 2011b) ++ ++ = ++ ++ ++
CI vs. ACD
  Arndt et al. (2011a, 2011b) ++ ++ = ++ ++ ++
*Assessed in the impaired/implanted ear only.
ACD, air conduction rerouting devices; BCD, bone conduction devices; CI, cochlear implantation; Hearing/Health RQOL, hearing/health-related quality of life; IE, impaired ear; IE < NE, less 
favorable SNR at the IE; IE > NE, more favorable SNR at the IE; IE = NE, similar SNRs at both ears; NE, nonimpaired ear; SIN, speech in noise; SIQ, speech in quiet; SNR, signal to noise ratio; ++, 
favors intervention statistically significant; +, favors intervention numerically; −−, favors comparator statistically significant; −, favors comparator numerically; =, no difference reported.
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Sound Lateralization and Localization
Sound localization was assessed in terms of a patient’s ability 
to determine the location of a sound from two or more possible 
locations. Methodologies for assessing localization were hetero-
geneous and precluded any meta-analyses from being conducted.
Rerouting Devices Versus Unaided • Only one study 
reported a significant benefit to sound localization from the 
use of a rerouting device (Tables 3 and 4, “LOC”). Saliba et al. 
(2011) reported an improvement in the ability to localize a 
sound to one of four spatial quadrants (front left/right, rear left/
right) with BCD use. Two studies reported significant deficits to 
localization performance after use of a rerouting device, one for 
BCD (Grantham et al. 2012) and one for ACD (Lin et al. 2006).
BCD Versus ACD • All five studies that compared the effect 
of ACD and BCD on sound localization found no difference 
with performance at chance levels regardless of device modality 
(Table 4, “LOC”).
CI Versus Unaided • Only one of the three studies that 
reported localization outcomes after CI found a statistically 
significant improvement compared with the unaided condition 
(Arndt et al. 2011a, b).
CI Versus Rerouting • Only one study compared localiza-
tion accuracy after CI with rerouting devices and observed that 
localization was significantly more accurate after CI compared 
with both ACD and BCD (Arndt et al. 2011a, 2011b).
Interim Summary • The evidence suggests that rerouting sig-
nals to the NE does not improve the ability to determine the 
location of a sound. There is currently a lack of evidence to 
indicate whether CI can restore the ability to localize sounds 
and meta-analysis of the available evidence is limited by the use 
of inconsistent testing methodologies.
Hearing- and Health-Related Quality of Life
The most frequent measures of hearing-related quality of life 
included the abbreviated profile of hearing aid benefit (APHAB, 
14 studies) and the speech, spatial, and qualities of hearing scale 
(SSQ, 7 studies). Measures of health-related quality of life were 
limited to two studies, with one using the SF-36 (Newman et al. 
2008) and the other using the Health Utilities Index Mark 3 
(HUI3; Arndt et al. 2011a, 2011b).
Rerouting Devices Versus Unaided • Significant benefits for 
BCD were reported in seven studies (Tables 3 and 4, hearing/
health-related quality of life [“hearing RQOL”]). A majority of 
these studies measured outcomes using the APHAB and signifi-
cant benefits were found on the ease of communication, back-
ground noise, and reverberation subscales. No study reported a 
significant benefit to hearing-related quality of life with ACD but 
one study did report a significant decrease in quality of life relat-
ing to an increased aversion to loud sounds (Lin et al. 2006). Two 
studies measured the impact of rerouting devices on health-related 
quality of life and reported no significant benefits (Newman et al. 
2008; Arndt et al. 2011a, 2011b; Tables 3 and 4, “health RQOL”).
Meta-analyses were conducted using data from studies that 
compared APHAB before and after use of a rerouting device sep-
arately for BCD and ACD devices (Fig. 2). Significant benefits 
from BCD use were found for all subscales except for aversion 
to loud sounds (AV) and significant benefits for ACD were found 
only for background noise and reverberation (Table 5, “APHAB”; 
see Figure, Supplemental Digital Content 8 and 9 (http://links.
lww.com/EANDH/A271 and http://links.lww.com/EANDH/
A272), which lists the individual study estimates for BCD and 
ACD, respectively). Additional meta-analyses were conducted on 
SSQ data but no significant effects were identified for either bone 
or air conduction (Table 5, “SSQ”; see Figure, Supplemental Dig-
ital Content 10 and 11 (http://links.lww.com/EANDH/A273 and 
http://links.lww.com/EANDH/A274), which list the individual 
study estimates for ACD and BCD, respectively).
BCD Versus ACD • None of the five studies that compared 
rerouting modalities found statistically significant differences in 
hearing-related quality of life between BCD and ACD (Table 4, 
Fig. 3. A summary of the random effects meta-analysis results comparing 
BCDs with ACDs. Symbols indicate the summary effect size for each sub-
scale of a self-reported outcome measure (SSQ) and for each condition of a 
behavioral measure of speech perception in noise (HINT). Error bars report 
95% confidence intervals for the summary effects. ACD indicates air con-
duction rerouting devices; BCD, bone conducting rerouting devices; SSQ, 
speech, spatial, and qualities of hearing.
Fig. 2. A summary of the random effects meta-analysis results comparing 
air- and bone conduction rerouting (ACD and BCD, respectively) and CI to 
the unaided condition. Symbols indicate the summary effect size for each 
subscale of two self-reported outcome measures (APHAB and SSQ) and 
for each condition of a behavioural measure of speech perception in noise 
(HINT). Error bars report 95% confidence intervals for the summary effects. 
ACD indicates air conduction rerouting devices; APHAB, abbreviated pro-
file of hearing aid benefit; BCD, bone conduction rerouting devices; CI, 
cochlear implantation; SSQ, speech, spatial, and qualities of hearing.
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“hearing RQOL”). Only SSQ data could be pooled across stud-
ies and only for the spatial dimension (Fig. 3). No significant 
effect of conduction modality was found (Table 5, “SSQ”; see 
Figure, Supplemental Digital Content 12 (http://links.lww.com/
EANDH/A275), which lists the individual study estimates for 
the difference between BCD and ACD).
CI Versus Unaided • All studies that compared hearing-related 
quality of life before and after CI found significant benefits 
(Table 4, “hearing RQOL”). Three studies reported a significant 
decrease in self-reported difficulties with listening using the SSQ 
(Vermeire et al. 2009; Arndt et al. 2011a, 2011b; Távora-Vieira 
et al. 2013). A meta-analysis of this SSQ data found significant 
decreases in listening difficulty on the speech, spatial, and quali-
ties subscales (Fig. 2, Table 5 “SSQ”; see Figure, Supplemental 
Digital Content 13 (http://links.lww.com/EANDH/A276), which 
lists the individual study estimates for CI).
CI Versus Rerouting • Only one study compared CI with rerouting 
devices (Arndt et al. 2011a, 2011b). The study reported significant 
benefits on measures of hearing-related (SSQ) and health-related 
(HUI3) quality of life after implantation compared with 3-week tri-
als of both an ACD and a headband-mounted BCD (Table 4).
Interim Summary • Compared with the unaided condition, 
both rerouting devices and CI appear to have beneficial effects on 
hearing-related quality of life by reducing the level of listening 
difficulty experienced in everyday situations. There is currently 
an absence of evidence that either conduction modality for rerout-
ing signals between the ears reduces listening difficulties more 
than the other. No conclusion can yet be drawn about whether 
CI provides additional reductions to listening difficulty compared 
with rerouting devices. There is a lack of evidence for the effects 
of any intervention on health-related quality of life.
Complications and Adverse Events
Three studies reported information about complications related 
to BCD use. Gluth et al. (2010) reported eight cases of skin reactions 
around the site of an abutment. Soft-tissue surgery was performed 
in 2 cases and 1 case required relocation of the abutment due to 
infection. One patient reported pain that led to discontinued use of 
the device. Wazen et al. (2003) reported one case of skin ulceration 
around an abutment that healed and did not affect device use. Mur-
ray et al. (2011) reported 4 cases with minor soft-tissue changes 
and 1 case of minor irritation after a trial of a dental-mounted BCD. 
None of the 27 studies discussed the reporting of adverse events.
DISCUSSION
The scientific literature was searched using a systematic 
approach to identify studies that evaluated benefits of hearing 
TABLE 5. Random effects meta-analyses of speech perception (HINT Sentence test) and hearing-related quality of life (APHAB and 
SSQ) data
Comparison Outcome Scale/Condition N studies MD SMD (95% CI) I2 (%)
BCD vs. unaided APHAB RV 9 16.8% 0.8 (0.5–1.1) 43
EC 9 11.7% 0.6 (0.4–0.8) 0
BN 9 19.5% 0.8 (0.5–1.1) 27
AV 7 3.9% 0.1 (−0.2 to 0.4) 38
SSQ Speech 2 10.5% 0.8 (−1.1 to 2.8) 95
Spatial 3 10.9% 0.6 (−0.02 to 1.3) 73
Qualities 2 5.6% 0.5 (−1.0 to 1.9) 92
HINT SIQ 3 0.05 dB 0.1 (−0.2 to 0.4) 0
S0N0 4 0.7 dB 0.4 (−0.03 to 0.8) 55
S0Nne 4 2.5 dB 0.5 (0.1–0.9) 46
S0Nie 4 −2.3 dB −0.5 (−0.8 to −0.2) 0
ACD vs. unaided APHAB RV 4 6.8% 0.5 (0.2–0.8) 0
EC 4 3.8% 0.3 (−0.1 to 0.6) 0
BN 4 10.6% 0.5 (0.2–0.8) 0
AV 4 −3.3% −0.1 (−0.6 to 0.3) 43
SSQ Spatial 2 9% 0.4 (−0.1 to 0.9) 0
HINT SIQ 2 −2.2 dB −0.3 (−0.7 to 0.1) 0
S0N0 2 −0.2 dB −0.1 (−0.5 to 0.3) 0
S0Nne 2 2.6 dB 0.7 (0.1–1.3) 32
S0Nie 2 −3.9 dB −0.8 (−1.3 to −0.3) 0
BCD vs. ACD SSQ Spatial 2 −1.8% −0.1 (−0.5 to 0.4) 0
HINT SIQ 2 1.7 dB 0.5 (−0.5 to 1.4) 76
S0N0 2 1.5 dB 1.0 (0.5–1.6) 7
S0Nne 2 1.3 dB 0.3 (−0.1 to 0.8) 0
S0Nie 2 1.9 dB 0.4 (−0.1 to 0.8) 0
CI vs. unaided SSQ Speech 3 25.0% 1.0 (0.6–1.5) 0
Spatial 3 33.8% 1.3 (0.7–1.9) 0
Qualities 3 15.3% 0.6 (0.1–1.0) 22
MDs report the average change in the original units of the outcome measure. Effect sizes are reported as SMDs that express pre-post differences as a multiple of their SD. Positive MDs and 
SMDs indicate more favorable outcomes with the intervention. Effects in bold font are significantly greater than zero. Heterogeneity is expressed in terms of an I2 value and marked in bold font 
if found to be significant based on a χ2 test.
95% CI, 95% confidence intervals; APHAB, abbreviated profile of hearing aid benefit; BN, background noise; EC, ease of communication; MD, mean differences; N studies, number of studies 
included; RV, reverberation; S0N0, speech and noise from in front; S0Nne, speech front, noise on nonimpaired side; S0Nie, speech front, noise on impaired side; SIQ, speech in quiet; SMD, 
standardized mean differences; SSQ, speech, spatial, and qualities of hearing.
Copyright © 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
504  KITTERICK ET AL. / EAR & HEARING, VOL. 37, NO. 5, 495–507
instruments in adults with a unilateral sensorineural severe to 
profound hearing loss. Studies primarily examined changes in 
self-reported difficulties with listening and behavioral measures 
of speech perception before and after providing patients with a 
device that either rerouted sounds from the impaired to the NE 
or restored aspects of hearing to the IE.
Rerouting Devices
The evidence suggests that rerouting devices can both 
improve and degrade speech perception in noise but can also 
reduce self-reported difficulty with listening. Statistically sig-
nificant benefits to speech perception were found only when 
the SNR was more favorable at the impaired than at the NE. In 
this situation, a rerouting device increases the SNR at the NE 
by overcoming the head-shadow effect (Pumford 2005). Some 
evidence of heterogeneity in the effect sizes was also found for 
both air and bone conduction devices (ACD, I2 = 32%; BCD, 
I2 = 46%). For example, the size of the benefit from BCD 
devices ranged from an improvement in SNR of just 0.4 dB 
(Saliba et al. 2011) to a more substantial 4.4 dB (Niparko et al. 
2003). Thus, uncertainty remains about the size of the benefit 
that patients may receive even under listening conditions that 
favor the use of a rerouting device and whether the magnitude 
of the benefit would be clinically meaningful.
When the SNR was less favorable at the IE, rerouting actu-
ally hindered performance. The meta-analysis revealed that the 
average size of the degradation in performance on the HINT 
sentence test (increase in SNR: ACD: 3.9 dB, BCD: 2.3 dB) was 
similar to or larger than the size of the benefit observed when 
the SNR was more favorable at the IE (decrease in SNR: ACD: 
2.6 dB, BCD: 2.5 dB). Patients may, therefore, require coun-
seling to form appropriate expectations about the situations in 
which benefit may be obtained and those in which the use of a 
rerouting device may be counterproductive to listening. The fact 
that the effect of a rerouting device can be highly dependent on 
the listening situation in which it is used may also explain why 
the meta-analysis found significant effects on one self-reported 
outcome (APHAB) but not another (SSQ), and also why mod-
erate-to-high levels of heterogeneity (I2 >4 0%) were observed 
on many of their subscales.
The evidence also suggests that rerouting devices do not 
aid the listener to localize sounds. This conclusion is compat-
ible with the fact that localization abilities are largely depen-
dent on binaural cues (Akeroyd 2006) and rerouting devices do 
not restore two-eared hearing. Some have speculated that these 
devices may provide cues that enable a listener to distinguish 
sounds on the left from sounds on the right (lateralization) by 
distorting the spectral content of sounds transmitted through 
the device (Harford & Barry 1965; Vaneecloo et al. 2001). 
The ability of the current review to synthesize evidence for the 
effects of rerouting devices on spatial listening was hindered 
by heterogeneity in the assessment methodologies used across 
studies. However, even when multiple studies assessed spatial 
listening using the same self-report questionnaire (SSQ), the 
meta-analysis identified that there were only small and nonsig-
nificant effects for both ACD (effect size, 0.4) and BCD (effect 
size, 0.6) with significant heterogeneity in effect sizes across 
studies for the latter (BCD, I2 = 79%). Therefore, the current 
review identified a lack of evidence to suggest that devices that 
reroute sounds to the NE provide reliable cues to support spatial 
hearing.
Restorative Devices
This review identified limited evidence for the effects of CI 
on speech perception in noise. Although significant benefits 
were reported individual by three studies when the SNR was 
more favorable at the IE, the evidence could not be synthesized 
and subjected to a meta-analysis in this and other configurations 
of speech and noise due to fact that the assessment methodolo-
gies were not consistent across studies. The meta-analysis did 
identify effects relating to reductions in self-reported difficul-
ties with listening to speech that were medium in size (SSQ 
speech: mean reduction 25%, SMD = 1.0) and consistent across 
studies (I2 = 0%). Although this evidence may suggest that the 
impact of any benefits to speech perception after implantation 
may extend to situations in everyday life, further evidence for 
the effects of CI on speech perception under controlled condi-
tions is required to establish the bases of these reductions in 
listening difficulties.
CI also has the capacity to improve localization for individu-
als with residual hearing in the contralateral ear (Seeber et al. 
2004). However, only one out of four studies that assessed sound 
localization before and after CI identified a statistically signifi-
cant improvement (Arndt et al. 2011a, 2011b). The lack of a 
single power calculation raises doubts over whether the studies 
were capable of detecting such an effect. Although implanta-
tion undoubtedly restores some form of bilateral input, it is still 
unclear whether it can restore spatial hearing in the unilaterally 
deaf and over what timescale. The consistent (I2 = 0%) and large 
(SMD > 1.2) reduction in self-reported spatial listening diffi-
culties after implantation (SSQ spatial: mean reduction 34%) 
could suggest that the assessment methods were insensitive to 
the particular benefits experienced by these individuals. Alter-
natively, implantation may have improved the ability to later-
alize sounds, which these studies did not assess, or may have 
created a perception of spatial listening by improving the aware-
ness of sounds on the impaired side. As with the self-reported 
reductions in difficulties with listening to speech, elucidating 
the bases of these perceived benefits to spatial listening will 
require further assessments of sound localization abilities under 
controlled conditions and the use of consistent testing method-
ologies across studies.
Choice of Intervention
Evidence for the relative effectiveness of the various inter-
ventions identified in the review was sparse. A meta-analysis 
of two studies (Niparko et al. 2003; Wazen et al. 2003) sug-
gested that BCD conferred additional benefits to speech per-
ception compared with ACD but only when speech and noise 
were colocated. The effect was of medium size (SMD = 1.0) 
and consistent across the two studies (I2 = 7%). However, the 
nature of the improvement was that listeners could tolerate an 
additional decrease in SNR of only 1.5 dB on average and it 
is unclear whether the size of this effect would be considered 
clinically meaningful.
The two studies that were included in that meta-analysis 
were from a subset of four studies that compared BCD and ACD 
using nonrandomised designs (Bosman et al. 2003; Niparko 
et al. 2003; Wazen et al. 2003; Lin et al. 2006; Table 4, BCD 
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versus ACD). As all these studies evaluated BCDs mounted on 
a surgically implanted abutment, it is possible that those who 
had committed to surgery in these nonrandomised studies were 
primarily interested in receiving a BCD and may have been less 
willing to report benefit from ACD use during a preoperative 
trial. Although two studies did randomized the order of ACD 
and BCD trials by using head-band mounted BCD models (Hol 
et al. 2010b; Arndt et al. 2011a, 2011b), they did not assess 
speech perception consistently and therefore it was not possible 
to pool their data for meta-analysis. Thus, the statistically sig-
nificant benefit observed for BCD over ACD in one particular 
spatial configuration of speech and noise should be interpreted 
with caution.
There are physical differences between BCD and ACD 
devices that could plausibly give rise to preferences for one over 
the other including whether the patient has to wear two devices 
(ACD) or only one (BCD) and whether the NE is occluded 
(ACD) or not (BCD). Differences in the intensity of rehabili-
tation, which was likely to be higher after abutment-mounted 
BCD provision compared with ACD provision, may also pro-
duce differences in outcome that are not a direct function of 
the conduction modality. However, no study was identified 
that compared the relative benefits of an abutment-mounted 
BCD and an ACD where these potential confounding factors 
were controlled for, and only one study compared CI to either 
ACD or BCD (Arndt et al. 2011a, 2011b). There is, therefore, 
a lack of evidence for the relative benefits of different rerouting 
modalities and for the additional benefits, if any, of CI over the 
rerouting of signals to the NE.
Recommendations
The lack of prospective controlled trials and the exclusion of 
patients who provided incomplete data raise concerns about the 
potential for selection bias to influence the observed effects. As a 
result, no recommendations for the management of unilaterally 
deaf adults can be based on the current evidence. The follow-
ing recommendations, therefore, aim to ensure that future stud-
ies are of sufficient quality to strengthen the evidence base for 
hearing instruments for unilateral deafness. The primary recom-
mendation is that randomized controlled trials should be con-
ducted to compare ACD and BCD devices (whether mounted on 
a head-band or abutment) to the unaided condition and to each 
other, and also to compare CI with rerouting devices. If further 
cohort or case–control studies are undertaken, they should be 
well designed, appropriately powered, planned prospectively 
with detailed inclusion criteria, and should recruit from multi-
ple sites. The effect sizes provided by the current meta-analysis 
(Table 5) could be used to inform the sample size calculations 
for future studies.
It is also recommended that those conducting further studies 
of the effectiveness of hearing instruments for unilateral severe to 
profound sensorineural hearing loss consider supporting future 
efforts to synthesize new and existing evidence when selecting 
outcome measures and when reporting the results of any further 
studies. Where studies seek to measure the benefits to speech per-
ception in noise, it is recommended that outcomes should include 
SRTs for IE < NE, IE > NE, and IE = NE conditions as the cur-
rent evidence suggests they may be useful in demonstrating both 
the benefits and potential drawbacks of different hearing instru-
ments. Where studies aim to assess benefits to spatial listening 
abilities, it is recommended that the methodology should include 
the presentation of sounds to the left and right of straight ahead 
to permit the reporting of performance in terms of percent cor-
rect sound lateralization. Few studies have assessed lateralization 
explicitly and uncertainty remains as to whether certain hearing 
instruments may only aid gross spatial judgments rather than finer 
judgments of spatial location. Where studies wish to assess these 
finer judgments using localization tasks, it is recommended that 
the reporting of results includes the mean unsigned localization 
error. The current literature has employed a range of localization 
performance metrics that cannot be compared directly and mean 
unsigned error represents a summary statistic that is straightfor-
ward to compute and to interpret.
In the absence of a patient-reported outcome instrument 
that has been validated specifically for use in unilaterally deaf 
adults and to detect the effects of rerouting and restorative 
devices, it is recommended that future studies should assess 
hearing-related quality of life using at least one of the two 
most commonly used instruments, the APHAB and the SSQ. 
These instruments appear to be sensitive to the impact of 
device use and may indicate whether improvements on labo-
ratory-based tests generalize to everyday listening situations. 
On a similar basis, it is recommended that all future studies 
include a generic preference-based instrument for measur-
ing health-related quality of life that is sensitive to interven-
tions for hearing, such as the HUI3, as only a single study 
was found to collect and report data on health-related quality 
of life. The use of generic instruments to provide preference-
based valuations of the health states associated with the use of 
different hearing instruments (“utility” values) is necessary to 
inform the health-economic evaluations that are increasingly 
underpinning commissioning decisions in publicly funded 
healthcare systems.
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